Down-regulated G protein-coupled receptor kinase 6 leads to apoptosis in multiple myeloma MM1R cells

被引:8
作者
Zhang, Zhiyao [1 ]
Li, Zhenyu [2 ]
Chen, Wenming [1 ]
机构
[1] Capital Med Univ, Beijing Chao Yang Hosp, Dept Hematol, 8 Gongti South Rd, Beijing 100020, Peoples R China
[2] Xuzhou Med Coll, Affiliated Hosp, Dept Hematol, Xuzhou 221002, Jiangsu, Peoples R China
关键词
multiple myeloma; MM1R; GRK6; apoptosis; STAT3; GRK6-DEFICIENT MICE; STAT3; ACTIVATION; GRK6; EXPRESSION; IN-VITRO; SURVIVAL; SUPPRESSION; CHEMOTAXIS;
D O I
10.3892/etm.2018.6722
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
G protein-coupled receptor kinase 6 (GRK6) is highly expressed in multiple myeloma (MM) cell lines, but absent or only weakly expressed in most primary human somatic cells. In the present study, GRK6 expression was assessed in MM patients and healthy individuals by quantitative polymerase chain reaction. Flow cytometry were performed to measure the apoptosis of lentivial-transfected MM1R cells. Western blot analysis was performed to assess the apoptosis and signal transducer and activator of transcription 3 pathway-related factors. The results demonstrated that GRK6 was differentially expressed in individuals who suffered from MM and healthy individuals. Previous studies have shown that downregulating GRK6 has anti-cancer effects in the MM cell line, MM1R. The present study demonstrated that RNA interference-mediated GRK6 knockdown promoted apoptosis in the MM1R cell line. Therefore, we hypothesized that GRK6 plays a significant role in determining the course of MM.
引用
收藏
页码:4253 / 4259
页数:7
相关论文
共 27 条
[1]   Nuclear factor-κB and STAT3 are constitutively active in CD138+ cells derived from multiple myeloma patients, and suppression of these transcription factors leads to apoptosis [J].
Bharti, AC ;
Shishodia, S ;
Reuben, JM ;
Weber, D ;
Alexanian, R ;
Raj-Vadhan, S ;
Estrov, Z ;
Talpaz, M ;
Aggarwal, BB .
BLOOD, 2004, 103 (08) :3175-3184
[2]   Interleukin-6-dependent gene expression profiles in multiple myeloma INA-6 cells reveal a Bcl-2 family-independent survival pathway closely associated with Stat3 activation [J].
Brocke-Heidrich, K ;
Kretzschmar, AK ;
Pfeifer, G ;
Henze, C ;
Löffler, D ;
Koczan, D ;
Thiesen, HJ ;
Burger, R ;
Gramatzki, M ;
Horn, F .
BLOOD, 2004, 103 (01) :242-251
[3]   Stat3 as an oncogene [J].
Bromberg, JF ;
Wrzeszczynska, MH ;
Devgan, G ;
Zhao, YX ;
Pestell, RG ;
Albanese, C ;
Darnell, JE .
CELL, 1999, 98 (03) :295-303
[4]  
CHUANG TT, 1992, J BIOL CHEM, V267, P6886
[5]   Functional Consequences of Perturbed CXCL12 Signal Processing: Analyses of Immature Hematopoiesis in GRK6-Deficient Mice [J].
Chudziak, Doreen ;
Spohn, Gabriele ;
Karpova, Darja ;
Dauber, Katrin ;
Wiercinska, Eliza ;
Miettinen, Johanna A. ;
Papayannopoulou, Thalia ;
Boenig, Halvard .
STEM CELLS AND DEVELOPMENT, 2015, 24 (06) :737-746
[6]   β-arrestins and cell signaling [J].
DeWire, Scott M. ;
Ahn, Seungkirl ;
Lefkowitz, Robert J. ;
Shenoy, Sudha K. .
ANNUAL REVIEW OF PHYSIOLOGY, 2007, 69 :483-510
[7]  
Ek I J, 1990, Fag Tidsskr Sykepleien, V78, P26
[8]   Defective lymphocyte chemotaxis in β-arresting2-and GRK6-deficient mice [J].
Fong, AM ;
Premont, RT ;
Richardson, RM ;
Yu, YRA ;
Lefkowitz, RJ ;
Patel, DD .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (11) :7478-7483
[9]   COSMIC 2005 [J].
Forbes, S ;
Clements, J ;
Dawson, E ;
Bamford, S ;
Webb, T ;
Dogan, A ;
Flanagan, A ;
Teague, J ;
Wooster, R ;
Futreal, PA ;
Stratton, MR .
BRITISH JOURNAL OF CANCER, 2006, 94 (02) :318-322
[10]   STAT3 as a central mediator of neoplastic cellular transformation [J].
Frank, David A. .
CANCER LETTERS, 2007, 251 (02) :199-210